Georgia Man Joins MDL Over Stryker Rejuvenate Hip Implant

A Georgia resident has joined the multidistrict litigation against Stryker Corporation and its subsidiary Howmedica Osteonics alleging the hip implant manufacturer failed to adequately warn consumers about the risks of side effects of the replacement hip implant. Plaintiff Glen M. and his... Read More »

0

Eliquis Antidote Shows Good Results in New Study

  Three pharmaceutical companies working together on a possible antidote for Eliquis bleeding have announced the results of a study on the efficacy and safety of that antidote. Portola Pharmaceuticals, Bristol-Myers Squibb Company, and Pfizer, Inc. are cooperating to develop a medication... Read More »

0

Zithromax Use May Lead to Severe SJS Reaction

Stevens Johnson Syndrome (SJS) is a potentially fatal allergic reaction to medication such as the antibiotic Zithromax. Zithromax SJS can arise at any time and  can occur even after the patient has used the medication for a long time with no adverse reaction. What... Read More »

0

Ohio Couple Files Xarelto Lawsuit

Ohio plaintiffs William and Virginia B. recently filed a Xarelto lawsuit after William suffered from severe injuries as a result of taking Xarelto. This Xarelto lawsuit is just one of hundreds that Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals face, claiming the drug... Read More »

0

Study Hints at Possible Cause of Lipitor Diabetes

It’s been known for a while that statin medications like Lipitor may be related to an increased risk of developing type-2 diabetes. A new study shows that increase may have something in common with the lower risk of diabetes found in persons... Read More »

0

Anti-Convulsant Drug Dilantin Carries Risk of SJS

Dilantin is an anticonvulsant medication that is used to treat seizures that may occur during or after brain or nervous system surgery, particularly in people who have epilepsy. However, recently Dilantin has been linked to a serious and often fatal allergic reaction known... Read More »

0

Experts Explain Birth Control and Pseudotumor Cerebri

Women across the country are discovering that their most reliable and popular birth control products are allegedly causing tumor-like symptoms and permanent blindness. The condition in question, pseudotumor cerebri (PTC), has been reported to occur from various birth control users like: Yaz,... Read More »

0

Diabetes Medication Onglyza Linked to Heart Failure

Product liability attorneys are seeking potential plaintiffs to bring Onglyza lawsuits against the pharmaceutical manufacturers Bristol-Meyers Squibb and AstraZeneca. According to new studies, many medical researchers believe that using the diabetes drug Onglyza increases a patient’s risk of heart failure, pancreatic cancer,... Read More »

0

Essure Complications Will Get FDA Panel Review

The Food and Drug Administration has announced plans for a meeting of their Obstetrics and Gynecology Devices Panel to discuss the safety and effectiveness of the Essure birth control device. Background on Essure Essure is an implantable contraceptive device meant to be a non-surgical... Read More »

0

Judge Grants Partial Summary Judgment in IVC Filter Lawsuit

An IVC filter lawsuit was truncated somewhat when the judge granted partial summary judgment to defendant C.R. Bard concerning allegations over failure to warn, manufacturing defects and negligent misrepresentation. However, plaintiff Denise O.’s claims over alleged design flaws and the need for punitive damages... Read More »

0

New Low-T Drug Complaint Adds to Growing MDL

An Alabama man has added another complaint to the ongoing testosterone product multidistrict litigation after suffering from a stroke allegedly caused by the low-t medications he was taking. Plaintiff Kevin L. of Alabama is suing the makers of AndroGel, Axiron, and Depo-Testosterone for failing... Read More »

0

New Benicar Lawsuit Filed in Federal Court

A new Benicar lawsuit was recently filed in federal court. The lawsuit alleges that Daiichi Sankyo and Forest Laboratories and their subsidiaries failed to provide sufficient research and failed to warn about serious risks of gastrointestinal disorders associated with using the medication.... Read More »

0

Pradaxa Antidote Shows Promise in New Study

Amidst intense litigation regarding allegations of uncontrollable bleeding, the pharmaceutical manufacturer Boehringer Ingelheim has announced an antidote for their popular anticoagulant Pradaxa. Pradaxa has been at the center of serious bleeding allegations for the past several years, but a new study published... Read More »

0